ArticleFrontiers in oncology2021
Differentiating Between Multiple Myeloma and Metastasis Subtypes of Lumbar Vertebra Lesions Using Machine Learning-Based Radiomics.
Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.
- Accuracy of artificial intelligence in detecting tumor bone metastases: a systematic review and meta-analysis.BMC cancer · 2025Pooled it
- Artificial Intelligence for Detection and Characterisation of Bone Metastases on MRI: A Scoping Review.Cancers · 2026Review
- Automatic detection of spinal pathologies based on MRI scans.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026Article
- Artificial Intelligence in Hematologic Malignancies: Opportunities, Challenges, and Clinical Integration.Cureus · 2026Review
- A quantum machine learning framework for predicting drug sensitivity in multiple myeloma using proteomic data.Scientific reports · 2025Article
- Article
- Detection of early relapse in multiple myeloma patients.Cell division · 2025Article
- Extensive thoracic vertebral and chest wall metastases as the initial presentation of breast cancer: a case report and literature review.Frontiers in oncology · 2025Review
- Oncologic Applications of Artificial Intelligence and Deep Learning Methods in CT Spine Imaging-A Systematic Review.Cancers · 2024Review
- Radiomics model based on MRI to differentiate spinal multiple myeloma from metastases: A two-center study.Journal of bone oncology · 2024Article
- Curation of myeloma observational study MALIMAR using XNAT: solving the challenges posed by real-world data.Insights into imaging · 2024Article
- Recent advances in imaging and artificial intelligence (AI) for quantitative assessment of multiple myeloma.American journal of nuclear medicine and molecular imaging · 2024Review
- Computational Modeling, Augmented Reality, and Artificial Intelligence in Spine Surgery.Advances in experimental medicine and biology · 2024Review
- Common differential diagnosis of low back pain in contemporary medical practice: a narrative review.Frontiers in medicine · 2024Review
- Current Status and Future of Artificial Intelligence in MM Imaging: A Systematic Review.Diagnostics (Basel, Switzerland) · 2023Review
- Lumbar MR-based radiomics nomogram for detecting minimal residual disease in patients with multiple myeloma.European radiology · 2023Article
- Radiomics Analysis for Multiple Myeloma: A Systematic Review with Radiomics Quality Scoring.Diagnostics (Basel, Switzerland) · 2023Review
- Application of Machine Learning for Differentiating Bone Malignancy on Imaging: A Systematic Review.Cancers · 2023Review
- Differentiating Multiple Myeloma and Osteolytic Bone Metastases on Contrast-Enhanced Computed Tomography Scans: The Feasibility of Radiomics Analysis.Diagnostics (Basel, Switzerland) · 2023Article
- MRI-based radiomics nomogram for differentiation of solitary metastasis and solitary primary tumor in the spine.BMC medical imaging · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo determine whether machine learning based on conventional magnetic resonance imaging (MRI) sequences have the potential for the differential diagnosis of multiple myeloma (MM), and different tumor metastasis lesions of the lumbar vertebra.
methodsWe retrospectively enrolled 107 patients newly diagnosed with MM and different metastasis of the lumbar vertebra. In total 60 MM lesions and 118 metastasis lesions were selected for training classifiers (70%) and subsequent validation (30%). Following segmentation, 282 texture features were extracted from both T1WI and T2WI images. Following regression analysis using the least absolute shrinkage and selection operator (LASSO) algorithm, the following machine learning models were selected: Support-Vector Machine (SVM), K-Nearest Neighbor (KNN), Random Forest (RF), Artificial Neural Networks (ANN), and Naïve Bayes (NB) using 10-fold cross validation, and the performances were evaluated using a confusion matrix. Matthews correlation coefficient (MCC), sensitivity, specificity, and accuracy of the models were also calculated.
resultsTo differentiate MM and metastasis, 13 features in the T1WI images and 9 features in the T2WI images were obtained. Among the 10 classifiers, the ANN classifier from the T2WI images achieved the best performance (MCC = 0.605) with accuracy, sensitivity, and specificity of 0.815, 0.879, and 0.790, respectively, in the validation cohort. To differentiate MM and metastasis subtypes, eight features in the T1WI images and seven features in the T2WI images were obtained. Among the 10 classifiers, the ANN classifier from the T2WI images achieved the best performance (MCC = 0.560, 0.412, 0.449), respectively, with accuracy = 0.648; sensitivity 0.714, 0.821, 0.897 and specificity 0.775, 0.600, 0.640 for the MM, lung, and other metastases, respectively, in the validation cohort.
conclusionsMachine learning-based classifiers showed a satisfactory performance in differentiating MM lesions from those of tumor metastasis. While their value for distinguishing myeloma from different metastasis subtypes was moderate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.